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Abstract—Computational methods like classification and 
network-based algorithms can be used to understand the 
mode of action and the efficacy of a given compound and to 
help elucidating the patho-physiology of a disease.  In the 
pharmacological industry there has already been a shift 
from symptomatic oriented drugs that can relieve the 
symptoms but not the cause of the disease to pathology-
based drugs whose targets are the genes and proteins 
involved in the etiology of the disease. Drugs targeting the 
affected pathway have thus the potential to become 
therapeutic. A network approach to drug design would 
examine the effect of drugs in the context of a network of 
relevant protein regulatory metabolic interactions resulting 
in the development of a drug that would hit multiple targets 
selected in such a way as to decrease network integrity and 
so completely disrupt the functioning of the network. The 
screening of a compound to quickly identify the proteins it 
interacts with gives us all the necessary tools to identify and 
repair the deregulated biological pathway causing the 
disease. 
Keywords— Systems Biology, Protein Profiling, Network, 
Nodes & Edges, Attributes, Annotation etc. 
 
I. INTRODUCTION 
Systems Biology is the amalgamation of computer science, 
mathematics, physics and biology. It endeavors to study, 
analyze and understand complex biological systems by 
taking a coordinated integrated systems view using 
computational methodologies (1). Structure and dynamics 
of biological systems & prediction and inference in the 
complex systems is another significant implication (2).  
The aim of modern systems biology is to elucidate 
physiology and disease from the level of molecular 
pathways, regulatory networks, cells, tissues, organs and 
ultimately the whole organism. As currently employed, the 
term ‘systems biology’ encompasses many different 
approaches and models for probing and understanding 
biological complexity, and studies of many organisms from 
bacteria to man (3). Because biological complexity is an 
exponential function of the number of system components 
and the interactions between them, and escalates at each 
additional level of organization,  efforts are currently 
limited to simple organisms or to specific minimal 
pathways (and generally in very specific cell and 
environmental contexts) in higher organisms (4). Thus, 
methodologies that filter information for relevance, such as 
biological context and experimental knowledge of cellular 
and higher level system responses will be critical for 
successful understanding of different levels of organization 
in systems biology research (5). Systems biology 
approaches can provide a solution to design lifesaving and 
cost-effective drugs so that the diseases can be cured and 
prevented. Systems based computational techniques will be 
highly useful in designing effective therapeutic drugs (6, 7). 
System biology is defining biochemical networks in which 
biomolecules are showing the nodes and the molecular 
interactions between them are called the edges (8, 9). 
Analytical methods such as gene expression clustering (13), 
significance testing (14-17), and sequence motif 
identification (18) have been indispensable for enabling 
these discoveries and summarizing the data at each step. 
 
II. SYSTEM BIOLOGY PATHWAY MODELING 
Top-down modeling at the cell-to-organ and organism scale 
shows promise, but is extremely dependent on contextual 
cell response data. Moreover, to bridge the gap between 
omics and modeling, we need to collect a different type of 
cell biology data—data that incorporate the complexity and 
emergent properties of cell regulatory systems (10-12).  
Human tissues response can be probed ex vivo, an approach 
that, even with limitations in terms of availability and 
reproducibility of human tissues, has proven useful for 
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validating selected compounds and targets (19). Highly 
reproducible or even automated approaches to cell biology, 
however, seem more likely to contribute to the large-scale 
compound and gene function analyses desired by industry 
and required as a basis for modeling efforts.  Assays are 
generally designed to isolate individual pathways and to 
minimize biological complexity. This ‘systematic biology’ 
focus on simplified pathways is thus to be distinguished 
from the ‘systems biology’ focus on complexity and 
emergent properties (20,21). Complexity and emergent 
properties in biology derive from several features: first, 
complex inputs that stimulate multiple pathways; second, 
multiple outputs that are integrated network responses to the 
inputs; third, interactions between multiple cell types; and 
fourth, multiple contexts and environments for each cell 
type or combination of cell types (22). Efforts made to 
study cells in combination to mimic cell-cell interactions 
critical to in vivo regulatory networks and to assay cells in 
different complex environmental contexts (in which 
different combinations of pathways are activated). Parallel 
context or ‘multisystem’ analysis is important because 
proteins and pathways have evolved to integrate inputs and 
outputs from multiple contexts, so that to understand the 
effects of a drug (or target), data must be derived from cell 
responses in multiple environments (23). 
A panel of just four cell systems (combinations of 
endothelial cells and blood mononuclear cells in four 
different complex inflammatory environments) was found 
to embody complex biology reflecting distinctive 
contributions of many pharmacologic targets relevant to 
inflammation (24)  
encompassing the disease responses, profiles made up of as 
few as 24–40 protein readouts (including cytokines, 
chemokines, adhesion receptors and other inflammatory 
mediators) used to assess the responses of these complex 
systems are able to discriminate and classify most of the 
pathways and mechanisms effected by known modulators 
of inflammation, as well as a surprising array of other drugs 
and pathways tested. Importantly, the profiles generated 
from these complex, activated cell mixtures are 
reproducible, allowing archiving in databases and 
automated searching and analyses by profile similarity or 
other characteristics (e.g., effects on key disease-relevant 
parameters) (25). 
For target identification and validation, informatics 
approaches based on the similarity of database-stored 
multisystem profiles have been shown to rapidly associate 
gene or drug activities with known (or novel) pathways, and 
to predict functional pathways and network interactions 
(26). Clustering multisystem response profiles, in which the 
systems are designed to capture emergent properties, can 
thus help define the functional architecture of signaling 
networks, information important (in conjunction with 
conventional data sets) for designing and testing 
computational models. 
 
Fig.1: Research Impact from 2000 to 2015. System biology performs a search in PubMed to reveal the frequency each term 
appears in all publications listed in database. 
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Subject 
 
Year 
Bioinformatics Computational 
Biology 
Genome 
Wide 
Association 
Study 
Personalized 
Medicine 
Proteomics Single 
Nucleotide 
Protein 
System 
Biology 
2000 1505 1245 18 200 219 969 1246 
2002 3284 2635 38 288 1040 979 1688 
2004 6424 5032 71 392 2417 1486 2297 
2006 8901 6984 135 462 3522 2266 3115 
2008 10906 8746 572 748 4046 3310 4181 
2010 13463 11255 2669 1658 4682 4271 5242 
2012 16609 13690 3167 2721 5568 5474 6424 
2014 22322 16380 3318 4281 6427 6105 10153 
2015 24064 16359 3420 5332 6760 5628 11955 
 
Systematic two-hybrid screens and immunoprecipitation 
experiments are populating the public databases with 
thousands of protein-protein interactions and complexes 
(27, 28).  Other ongoing projects are defining large numbers 
of protein→DNA interactions (29), and protein microarrays 
are making it possible to map interactions between proteins 
and drugs, hormones, and other small molecules (30). These 
molecular interactions provide a paradigm for 
understanding changes in gene expression and for 
integrating a wide variety of global state measurements. 
One basis of systemic approaches to biological processes is 
the knowledge generated from genome sequencing and 
large-scale genetic analyses revealing an already enormous 
scale of interactions on the level of nucleic acids (31-33). A 
general understanding of the topology of genetic-interaction 
networks in yeast has a wider importance, because similar 
networks are expected to underlie the relationship between 
genotype and phenotype in higher eukaryotic species (34). 
 
III. SOFTWARE FOR USE IN SYSTEM 
BIOLOGY 
Cytoscape with its plug-ins: Cytoscape is an open source 
bioinformatics software tool which is used for the 
visualizing molecular interaction networks and integrating it 
with gene expression. Cytoscape was developed at the 
Institute of System Biology in Seattle in 2002. It is written 
in java and used in any java-based operating systems. 
Cytoscape is a project dedicated to building open-source 
network visualization and analysis software. Software 
"Core" provides basic functionality to layout and query the 
network and to visually integrate the network with state 
data. The Core is extensible through a plug-in architecture, 
allowing rapid development of additional computational 
analyses and features (35, 36). In present work we used the 
following four plug-ins- 
BioNetBuilder: BioNetBuilder is an open-source client-
server Cytoscape plug-in that offers a user-friendly interface 
to create biological networks integrated from several 
databases. Users can create networks for ~1500 organisms, 
including common model organisms and human. Currently 
supported databases include: DIP, BIND, Pro-links, KEGG, 
HPRD, The BioGrid, and GO, among others. The 
BioNetBuilder plug-in client is available as a Java Web 
start, providing a platform independent network interface to 
these public databases (37). 
jActiveModulus: Identification of Modules of Seed and 
Neighboring Genes Using the jActiveModule Method 
(jAM).The MT method results in a large number of 
statistically significant predictions, but some of the 
predictions may be artifacts of low or excessive 
connectivity. To address this concern, the jActiveModule 
method is implemented to determine modules with maximal 
proportions of the lowest p value genes. jActiveModule 
Plug-in enumerates those ids which are actively 
participating in one or more function after the incorporation 
of compound in the microbe has already taken place. The 
jActiveModule plug-in gives those ids which are point of 
interest of our result these ids specifically are the once 
which depict to be actively taking post in the functioning of 
the microbes (38). 
BiNGO: The Biological Networks Gene Ontology tool 
(BiNGO) is an open-source Java tool to determine which 
Gene Ontology (GO) terms are significantly 
overrepresented in a set of genes. BiNGO can be used either 
on a list of genes, pasted as text, or interactively on sub 
graphs of biological networks visualized in Cytoscape. 
BiNGO maps the predominant functional themes of the 
tested gene set on the GO hierarchy, and takes advantage of 
Cytoscape’s versatile visualization environment to produce 
an intuitive and customizable visual representation of the 
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results. The main advantage of BiNGO is its interactive use 
on molecular interaction networks, e.g. protein interaction 
networks or transcriptional co-regulation networks, 
visualized in Cytoscape. Furthermore, BiNGO offers great 
flexibility in the use of ontologies and annotations. Besides 
the traditional GO ontologies, BiNGO also supports the use 
of GO Slim ontologies, as well as custom ontologies and 
annotations (39).  
MCODE: "Molecular Complex Detection" (MCODE), that 
detects densely connected regions in large protein-protein 
interaction networks that may represent molecular 
complexes. The method is based on vertex weighting by 
local neighborhood density and outward traversal from a 
locally dense seed protein to isolate the dense regions 
according to given parameters. The algorithm has the 
advantage over other graph clustering methods of having a 
directed mode that allows fine-tuning of clusters of interest 
without considering the rest of the network and allows 
examination of cluster interconnectivity, which is relevant 
for protein networks (40). 
 
IV. FUTURE PROSPECTS 
Targets are prioritized because they are upregulated at the 
gene level in disease compounds are selected to be 
biochemically specific); animal models are considered 
essential. Markup languages for gene expression data, 
emerging ontologies for sharing and integrating different 
kinds of omics and conventional biological data and the 
introduction of standardized high-throughput systems 
biology and associated informatics approaches represent 
important first steps on this path. Computational biology 
and bioinformatics approaches have the potential to 
completely change the way drugs are discovered and 
designed. A shift from symptomatic oriented drugs that can 
relieve the symptoms but not the cause of the disease to 
pathology-based drugs whose targets are the genes and 
proteins involved in the etiology of the disease. Drugs 
targeting the affected pathway have thus the potential to 
become therapeutic. A network approach to drug design 
would examine the effect of drugs in the context of a 
network of relevant protein-protein, regulatory and 
metabolic interactions resulting in the development of a 
drug that would hit multiple targets selected in such a way 
as to decrease network integrity and so completely disrupt 
the functioning of the network. The screening of a 
compound to quickly identify the proteins it interacts with 
gives us all the necessary tools to identify and repair the 
unregulated biological pathway causing the disease. 
 
 
 
V. CONCLUSION 
The systems biology approaches outlined here are 
contributing to meaningful drug development decisions by 
accelerating hypothesis-driven biology. Modeling specific 
physiologic problems in target validation or clinical 
physiology and by providing rapid characterization and 
interpretation of disease-relevant cell and cell system level 
responses. An analogy can be drawn to the genome project, 
in which multiple individual efforts contributed technology 
and informatics approaches that eventually enabled a 
concerted ‘big science’ push to sequence the genome. The 
application of systems biology to medical practice is the 
future of medicine. Its realization will see drug discovery 
and the design of multiple drug therapies and therapeutic 
gene circuits being pursued just as occurs now with modern, 
complex engineering products. The daunting task ahead is 
to investigate our identified sub networks in the laboratory. 
Because large interaction networks are suspected to contain 
many false-positives, an initial experiment would be to 
verify that the interactions in each sub network are 
reproducible and present under the subnet’s particular set of 
conditions. Routine network screening has to be performed 
to define novel modes of regulation, to identify 
evolutionarily conserved pathways, or to interrogate 
regulatory circuits responding to the entire spectrum of 
drugs and human diseases. 
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